i-KAIST Lab Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,482
2,082
115
14,415
2,359
2,884
Total Accounts Receivable
6,688
8,226
3,854
4,517
5,317
2,051
Inventories
3,487
5,914
5,141
849
462
566
Other Current Assets
1,241
934
712
2,389
114
590
Total Current Assets
15,898
17,155
9,822
22,169
8,252
6,091
Net Property, Plant & Equipment
14,631
14,388
14,003
15,092
14,892
15,889
Total Investments and Advances
2,850
2,035
2,159
21,159
29,142
139,840
Long-Term Note Receivable
2,034
2,109
4,920
-
-
-
Intangible Assets
6,300
6,397
4,672
474
822
1,591
Other Assets
9,894
9,807
10,013
706
1,315
918
Total Assets
51,795
52,081
45,784
59,601
54,421
164,330
ST Debt & Current Portion LT Debt
24,100
22,752
22,110
21,236
19,281
Accounts Payable
10,284
12,956
13,401
18,116
7,013
Other Current Liabilities
3,432
2,272
2,234
4,420
2,989
Total Current Liabilities
37,815
37,980
37,745
43,772
29,282
Long-Term Debt
1,700
500
3,141
-
235
Provision for Risks & Charges
1,011
1,201
1,075
65
78
Deferred Taxes
188
190
194
4,276
4,276
Total Liabilities
40,525
39,681
41,962
48,113
33,871
Common Equity (Total)
11,269
12,399
3,822
11,445
20,512
Total Shareholders' Equity
11,269
12,399
3,822
11,445
20,512
Total Equity
11,269
12,399
3,822
11,488
20,550
Liabilities & Shareholders' Equity
51,795
52,081
45,784
59,601
54,421
Accumulated Minority Interest
-
-
-
43
39

About i-KAIST Lab Co.

View Profile
Address
27/F, Songdo Technopark IT Center
Inchon IN 21984
Korea, Republic Of
Employees -
Website http://www.gsinstrument.com
Updated 07/08/2019
POLUS BioPharm, Inc. engages in the manufacture and sale of electrical measuring, testing and analyzing instruments. Its main products include test and measuring instruments and telecommunication system. The test and measuring instruments consist of analyzer, analog oscilloscope, digital storage oscilloscope, generator, meter, counter, and power supply.